Ann: Acrux generic strategy and Axiron patent litigation update-ACR.AX, page-10

Some  random numbers in US$ - 1. assuming a % share of the 500m addressable market; and
2. ACR employs a similar partnering strategy based on royalty payments.... no milestones counted here.

not insignificant, but the challenge as always is guessing what the market share % achievable is.... IF they actually have/ can develop a good/superior product/application AND they can secure a capable partner AND negotiate acceptable commercial terms AND the partner is successful in marketing this product THEN there is significant upside for ACR...

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6
0		SCN1	SCN2	SCN3	SCN4	SCN5
1	Addressable market	500	500	500	500	500
2	Market share	5%	10%	15%	20%	25%
3	Opp Sales	25	50	75	100	125
4	Royalty	15%	15%	15%	15%	15%
5	ACR incremental Profit	4	8	11	15	19
6	Incremental EPS[/B]	0.02	0.05	0.07	0.09	0.12
7